Clinical Trial Details
| Trial ID: | L0550 |
| Source ID: | NCT02817555 |
| Associated Drug: | Epoetin Alfa |
| Title: | Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT02817555/results |
| Conditions: | Anemia|Chronic Kidney Disease |
| Interventions: | DRUG: Epoetin Alfa|DRUG: Darbepoetin alfa |
| Outcome Measures: | Primary: Cost of Erythropoiesis Stimulating Agent, total cost over 12 months in Canadian dollars, 12 months | Secondary: Hemoglobin, median hemoglobin (g/L) over 12 months, 12 months|Ferritin, mean ferritin (ug/L) over 12 months, 12 months|Transferrin Saturation (TSAT), median TSAT (%) over 12 months, 12 months|Iron Dose, median weekly iron dose (mg) over 12 months, 12 months|Iron Cost, total iron cost over 12 months in Canadian dollars, 12 months |
| Sponsor/Collaborators: | Sponsor: Andrea L Woodland |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 50 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2010-09 |
| Completion Date: | 2013-05 |
| Results First Posted: | 2019-09-10 |
| Last Update Posted: | 2019-09-10 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT02817555 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|